SCHEMBL9924233

SCHEMBL9924233

O=C(/N=C(/Nc1ccc(F)c(Cl)c1)N[C@H]1CC[C@H](Nc2ncccn2)CC1)c1ccc(F)c(F)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.49
MEN1 O00255 1/20 0.49
ALDH1A1 P00352 1/20 0.49
KCNQ3 O43525 1/20 0.44
KCNQ2 O43526 1/20 0.44
MALT1 Q9UDY8 6/20 0.43
MCHR1 Q99705 6/20 0.41
CSNK2A1 P68400 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.39
NR1I2 O75469 1/20 0.39
AHR P35869 1/20 0.39
NPC1 O15118 2/20 0.39
HTR1A P08908 1/20 0.39
ADRA2A P08913 1/20 0.39
ADRA1A P35348 1/20 0.39
HRH1 P35367 1/20 0.39
HTR2B P41595 1/20 0.39
NPY5R Q15761 1/20 0.39
RAB9A P51151 1/20 0.39
PDE4B Q07343 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9924422 0.91 KCNQ3 (0.42) KMT2AMEN1ALDH1A1KCNQ3KCNQ2
SCHEMBL9924419 0.88 KCNQ3 (0.41) KMT2AMEN1ALDH1A1KCNQ3KCNQ2
SCHEMBL9901952 0.88 KCNQ3 (0.41) KMT2AMEN1ALDH1A1KCNQ3KCNQ2
SCHEMBL9900852 0.88 KCNQ3 (0.41) KMT2AMEN1ALDH1A1KCNQ3KCNQ2
SCHEMBL9900854 0.88 KCNQ3 (0.41) KMT2AMEN1ALDH1A1KCNQ3KCNQ2
SCHEMBL17206691 0.88 KCNQ3 (0.41) KMT2AMEN1ALDH1A1KCNQ3KCNQ2
SCHEMBL9924230 0.86 MCHR1 (0.40) KCNQ3KCNQ2MCHR1HTR1AADRA2A
SCHEMBL9924143 0.85 EPHX2 (0.44) KMT2AMEN1KCNQ3KCNQ2MALT1
SCHEMBL9924253 0.85 MAPK1 (0.43) ALDH1A1MCHR1HTR1AADRA2AADRA1A
SCHEMBL9924126 0.85 SMN1; SMN2 (0.54) KMT2AMEN1ALDH1A1NR1I2AHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9169199-B2 Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2015-10-27 US disclosed
WO-2012078867-A2 CYCLOALKYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF LYCERA CORPORATION (US) 2012-06-14 WO disclosed